Market Research Reports and Industry Reports

Risk Reward of Developing a Herceptin Biosimilar A Thorough Assessment

  • DESCRIPTION
  • TABLE OF
    CONTENTS
  • RELATED
    REPORTS
  • SAMPLE REQUEST
  • REVIEWS
Herceptin exclusivity is expiring in major geographies and many Biosimilar players (both experienced and new entrant) are looking to have a share of this potential $6billion pie. Herceptin sales are critical to Roche as it comprise about 15% of its cumulative Pharma sales. While eying for this potential lucrative opportunity, there are several risks and barriers that Biosimilar players should be aware.

The report Risk Reward of Developing a Herceptin biosimilar A thorough assessment looks into several aspects of potential opportunity size for Biosimilar players, with regard to:

- European Experience of Biosimilars

- Current market positioning of Herceptin across geography

- Different technologies deployed by biosimilar players

- Competition Pipeline of Biosimilar and Biobetters targeting Herceptin

- Potential Market Expansion post expiry of Market Exclusivity

- Defense Strategies deployed by Roche

- Ongoing Clinical trials and their impact on Market Opportunity

- Global Regulatory Process and Hurdles

- Risk/Reward profile of developing Herceptin biosimilar
N/A

List Of Tables

N/A

List Of Figures

N/A

Payments Landscape in Australia: Opportunities and Risks to 2021

Payments Landscape in Australia: Opportunities and Risks to 2021GlobalDatas Payments Landscape in Australia: Opportunities and Risks to 2021 , report provides detailed analysis of market trends in the Australian cards and

USD 2750View Report

Payments Landscape in Brazil: Opportunities and Risks to 2021

Payments Landscape in Brazil: Opportunities and Risks to 2021GlobalDatas Payments Landscape in Brazil: Opportunities and Risks to 2021 , report provides detailed analysis of market trends in the Brazilian cards and

USD 2750View Report

Fill The Form For Sample Request
Name*
Email*
Mobile No.*
LandLine No.
Country Code.
There is no Reviews available

Delivery Details

PDF FORMAT REPORTS will be delivered by email within 12 to 24 hours after placing the order (Mon-Fri IST)

CHOOSE FORMAT

  • PDF    USD 2000
  • Site Licence    USD 4000
  • Enterprisewide Licence    USD 6000
$ 2000

Reports Details

Published Date : Feb 2013
No. of Pages :70
Country :Global
Category :Healthcare
Publisher :MP Advisors
Report Delivery By :Email
Report Delivery Time :12 to 24 hours after placing the order.

Customized Research

If you do not find this specific report suitable to your exact needs then you can also opt for customized research report that will befit all your expectation. To specify your requirements CLICK HERE

 

We Accept

payment
  • fb
  • twitter
  • pinterest
  • linckedin
  • rss
  • youtube